Status:
COMPLETED
VAS-2 Vasectomy With the Vax-X
Lead Sponsor:
University of Washington
Conditions:
Healthy
Eligibility:
MALE
30-55 years
Phase:
PHASE1
Brief Summary
The purpose of this research study is to study an experimental vasectomy device called the Vas-X. This is an experimental study of this new approach to vasectomy.
Detailed Description
The Vas-X works by stripping the lining of the vas deferens, the tube that sperm pass through during ejaculation. It is used in a way very similar to routine vasectomy, however, in a routine vasectomy...
Eligibility Criteria
Inclusion
- healthy male with normal physical findings
- normal testicular volume (15-30mL)
- detectable sperm in ejaculates
Exclusion
- Men with past history of
- hypertension
- significant cardiovascular
- thromboembolic disorders
- renal (including undiagnosed urinary tract bleeding)
- hepatic, prostatic and testicular disease
- prior vasectomy or scrotal surgery
- infertility
- Men with a past history of drug abuse will also be excluded.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00663533
Start Date
April 1 2008
End Date
July 1 2013
Last Update
December 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195